Cookie Consent by

Univ. Prof. Dr. Shahrokh Taghavi

Associate Professor of Surgery

Surgical Experience:    

Thoracic Surgery, Cardiac Surgery,Lung Transplantation, Heart Transplantation, Pulmonary Endarteriectomy




Higher Education:          

October 1985- March 1987        

Study of technical chemistry at the Technical University of Vienna


March 1987- July 1993  

Medical School at the Faculty of Medicine, University of Vienna



Professional Career:     

August 1993 – July 2002:             

Surgical resident at the Department of Cardiothoracic Surgery, University of Vienna


July 2002-July 2005        

Fellowship in Cardiac Surgery, Vienna

January 2005     

Associate Professor of Surgery, Vienna

July 2005-July 2008

Fellowship in Thoracic Surgery, Vienna

January 2010-Present   

Deputy Head of the Department of Thoracic Surgery, Vienna


Surgical Experience:     

  • Thoracic Surgery
  • Cardiac Surgery
  • Lung Transplantation
  • Heart Transplantation
  • Pulmonary Endarteriectomy


Institutional address:   

Department of Thoracic Surgery

General Hospital Vienna

Medical University Vienna

Waehringer Guertel 18-20

1090 Vienna, Austria


  • Consultation prices may vary depending on the number of files and documents you send


List of Publikations


1. T. Birsan, A. Zuckermann, O. Artermiou, O. Senbaklavci, S. Taghavi, G. Wieselthaler, G. Dekan, W. Wislocki, W. Klepetko. Bilateral lung transplantation for pulmonary hypertension.
Transplant Proc. 1997;29(7):2892-4.

2. T. Bîrsan, A. Zuckermann, S. Taghavi, O. Artemiou, O. Chevtchik, W. Klepetko und E. Wolner. Funktionelle Resultate und Langzeitergebnisse nach bilateraler Lungentransplantation bei pulmonaler Hypertonie. Wien Klin Wochenschrift 1998;110/2;45-52.

3. T. Bîrsan, S. Taghavi, W.  Klepetko. Treatment of Aspergillus related ulcerative tracheobronchitis in lung transplant recipients.(Letter to Editor) J Heart Lung Transplant 1998;17(4):437-8

4. T. Wekerle, W.  Klepetko, S. Taghavi, T. Bîrsan. Treatment of primary pulmonary hypertension and giant pulmonary artery aneurysm with bilateral lung transplantation and pulmonary artery reconstruction. Ann Thorac Surg 1998;65(3):825-7

5. A. Zuckermann, T. Bîrsan, S. Taghavi, O. Artemiou, N. Kupilik, G. Dekan, E. Wolner, W. Klepetko. Mycophenolate Mofetil in lung transplantation. Transplant Proc 1998;30:1514-6

6. T. Bîrsan, S. Taghavi, N. Kupilik, A. Pereszlenyi, O. Artemiou, G. Wolf, W. Klepetko.

Transperitoneale Unterbindung des Ductus thoracicus zur Behandlung eines Chylothorax nach Lungentransplantation. Acta Chir Austriaca Heft 2,1999

7. A. Zuckermann, T. Birsan, S. Taghavi, N. Kupilik, E. Deviatko, G. Dekan,  E. Wolner and W. Klepetko. Benifit of Mycophenolat mophetil in patients with cyclosporin A-induced   Nephropathy after lung transplantation. Transplant  proc 1999;31:1160-1161

8. S. Taghavi, T. Bîrsan, R. Seitelberger, N. Kupilik, P. Mares, A. Zuckermann , W.  Klepetko.Initial experience with two sequential anterolateral thoracotomies for bilateral       lung transplantation. Ann Thorac Surg 1999;67:1440-3.

9. W. Klepetko, S. Taghavi, A. Pereszlenyi, T. Bîrsan , J. Groetzner, N. Kupilik, O. Artemiou, E. Wolner. Impact of different coverage techniques on incidence of postpneumonectomy stump fistula. Eur J Cardiothorac Surg 1999;15(6):758-63.

10. S. Taghavi, T. Bîrsan, A. Pereszlenyi, N. Kupilik, P. Mares, A. Zuckermann, W. Klepetko.

Bilateral lung transplantation via two sequential anterolateral thoracotomies.

Eur J Cardiothorac Surg. 1999;15:658-662.

11. A. Zuckermann, W. Klepetko, T. Bîrsan, S. Taghavi, O. Artemiou, W. Wisser, G. Dekan and E. Wolner. Comparison between Mycophenolate Mofetil  and Azathioprin based immunosupressions in clinical lung transplantation. J Heart Lung Transplant 1999;18:432-440

12. T. Bîrsan, A. Kranz, P. Mares, O. Artemiou, S. Taghavi, A. Zuckermann, W. Klepetko.

Transient left ventricular failure following bilateral lung transplantation for pulmonary hypertension. J Heart Lung Tansplant 1999;18:304-309

13. W. Klepetko, W. Wisser, T. Bîrsan, P. Mares, S. Taghavi, N. Kupilik, E. Wolner

T4 lung tumors with infiltration of the thoracic aorta: is surgery                reasonable?

Ann Thorac Surg1999 Feb;67:340-4

14. P. Mares, TB. Gilbert, EM. Tschernko, M. Hiesmayer, M. Muhm, A. Herneth, S. Taghavi, W. Klepetko, I. Lang, W. Haider. Pulmonary artery thrombendarterectomy: a comparision of two different   postoperative treatment strategies. Anesth Analg. 2000;Feb;90(2):267-273.

15. A.Pereszlenyi, S. Harustiak, S. Taghavi, T. Birsan, E. Huber, E. Deviatko and W.

Klepetko. Lung transplantation today. Bratisl Lek Listy. 2000;101(2):63-70.


16. S. Taghavi, HJ. Ankersmit, G. Wieselthaler, M. Gorlitzer, A. Rajek, E. Wolner and M. Grimm. Extracorporeal Membrane oxygenation for graft failure after heart transplantation: Recent Vienna Experience. J Thorac Cardiovasc Surg. 2001 Oct;122(4):819-20.

17. SE. Sandner, G. Wieselthaler, A. Zuckermann, S. Taghavi, H. Schmidinger, R. Pacher, M. Ploner, G.Laufer, E. Wolner, M. Grimm. Survival benefit of the implantable cardioverter-defibrillator in patients on the waiting list for cardiac transplantation.Circulation 2001 Sep 18;104(12 Suppl 1):I171-6.

18. HJ. Ankersmit, GA. Wieselthaler, B. Moser, S. Taghavi, M. Grimm, G. Roth, M. Gorlitzer, H. Tschernich, R. Horvat, E. Wolner. Automated implantable cardiac defibrillator and biventricular Thoratec assist device as bridge to transplantation in a patient with sarcoidosis. J Thorac Cardiovasc Surg. 2001;121(6):1198-9.

19. S. Aharinejad, R. Schäfer, R. Hofbauer, D. Abraham, R. Blumer, A. Miksovsky, H. Traxler, D. Pullirsch, R. Alexandrowics, S. Taghavi, A. Kocher, G. Laufer. Impact of cardiac transplantation on molecular pathology of ET-1, VEGF-C and mitochondrial metabolism and morphology in dilated vs. ischemic cardiomyopathic patients. Transplantation 2001; 72:1043-9.

20. Abraham D, S. Taghavi, Riml P, Paulus P, Hofmann M, Baumann C, Kocher A, Klepetko W, Aharinejad S.VEGF-A and –C but not -B mediate increased vascular permeability in preserved lung grafts. Transplantation 2002:73:1703-6.

21. S. Taghavi , D. Abraham, P. Riml, P. Paulus, P. Schäfer, W. Klepetko, S. Aharinejad.Co-Expression of Endothelin-1 and Vascular Endothelial Growth Factor  Mediates Increased Vascular Permeability in Lung Grafts Prior to Reperfusion.

J Heart Lung Transplant 2002;21:600-3.

22. HJ. Ankersmit, B. Moser, A. Zuckermann, G. Roth , S. Taghavi, M. Brunner, E. Wolner, G. Boltz-Nitulescu.Activation-induced T cell death, and aberrant T cell activation via TNFR1 and CD95-CD95 ligand pathway in stable cardiac transplant recipients.

Cli Exp Immunol 2002 April;128(1):175-80

23. S. Taghavi, J. Ankersmit, A. Zuckermann, GA. Roth, G. Wieselthaler, A. Rajek, E. Wolner and M. Grimm. A retrospective analysis of extracorporeal membrane oxygenation versus right ventricular assist device in acute graft failure after heart transplantation. Transplant proc.2003;35:2805-7.

24. HJ. Ankersmit, G. Roth, A. Zuckermann, B. Moser, R. Obermaier, S. Taghavi, M. Brunner, G. Wieselthaler, M.  Lanzenberger, R. Ullrich, G. Laufer, M. Grimm, E. Wolner. Rapamycin as rescue therapy in a patient supported by biventricular assist device to heart transplantation with consecutive ongoing rejection. Am J Transplant.2003;3(2):231-4.

25. Aigner C, Jaksch P, Mazhar S, Czebe K, Marta G, S. Taghavi, Lang G, Klepetko W.

Treatment of severe acute lung allograft rejection with OKT3 and temporary extracorporeal membrane oxygenation bridging. Eur J Cardiothorac Surg. 2004;25(2):184-7.

26. C. Aigner, S. Mazhar, P. Jaksch, G. Seebacher, S. Taghavi, G. Marta, W. Wisser, W. Klepetko. Lobar transplantation, split lung transplantation and peripheral segmental resection--reliable procedures for downsizing donor lungs. Eur J Cardiothorac Surg. 2004;25(2):179-83.

27. S. Aharinejad, S. Taghavi, W. Klepetko, D. Abraham Hepatocyte Growth Factor Predicts Lung Transplantation Rejection. Lancet 2004;363(9420):1503-8.

28. Aigner C, Winkler G, Jaksch P, Ankersmit J, Marta G, Taghavi S, Wisser W, Klepetko W. Size-reduced lung transplantation: an advanced operative strategy to alleviate donor organ shortage.Transplant Proc. 2004 Nov;36(9):2801-5.

29. S. Taghavi, GM. Marta, G. Lang, G. Seebacher, G. Winkler, Katharina Schmidt and w. Klepetko Bronchial stump coverage with a pedicled pericardial flap: an effective method for prevention of postpneumonectomy bronchopleural fistula.

Ann Thorac Surg 2004;78:1644 –9.

30. S. Taghavi, A. Zuckermann, J. Ankersmit, G. Wieselthaler, A. Rajek,  G. Laufer, E. Wolner and M. Grimm. Extracorporeal Membrane Oxygenation is superior to right ventricular assist device for acute right ventricular failure after heart transplantation.

Ann Thorac Surg. 2005;79.

31. Aigner C, Winkler G, Jaksch P, Seebacher G, Lang G, Taghavi S, Wisser W, Klepetko W. Extended donor criteria for lung transplantation--a clinical reality.

Eur J Cardiothorac Surg. 2005 May;27(5):757-61.

32. Taghavi S, Krenn K, Jaksch P, Klepetko W, Aharinejad S.

Broncho-alveolar lavage matrix metalloproteases as a sensitive measure of bronchiolitis obliterans. Am J Transplant. 2005 Jun;5(6):1548

33. Aigner C, Jaksch P, Winkler G, Czebe K, Taghavi S, Marta G, Klepetko W.

Initial experience with oral valganciclovir for pre-emptive cytomegalovirus therapy after lung transplantation.Wien Klin Wochenschr. 2005 Jul;117(13-14):480-4.-52.

34. Aigner C, Jaksch P, Taghavi S, Wisser W, Marta G, Winkler G, Dekan G, Wolner E, Klepetko W. Donor total lung capacity predicts recipient total lung capacity after size-reduced lung transplantation. J Heart Lung Transplant. 2005 Dec;24(12):2098-102.

35. Zimpfer D, Heinisch B, Czerny M, Hoelzenbein T, Taghavi S, Wolner E, Grimm M.

Late vascular complications after extracorporeal membrane oxygenation support.

Ann Thorac Surg. 2006 Mar;81(3):892-5.

36. Krenn K, Klepetko W, Taghavi S, Lang G, Schneider B, Aharinejad S.

Recipient vascular endothelial growth factor serum levels predict primary lung graft dysfunction. Am J Transplant. 2007 Mar;7(3):700-6.

37. Aigner C, Wisser W, Taghavi S, Lang G, Jaksch P, Czyzewski D, Klepetko W.

Institutional experience with extracorporeal membrane oxygenation in lung transplantation.

Eur J Cardiothorac Surg. 2007 Mar;31(3):468-73; discussion 473-4.

38. Bonderman D, Skoro-Sajer N, Jakowitsch J, Adlbrecht C, Dunkler D, Taghavi S, Klepetko W, Kneussl M, Lang IM.

Predictors of outcome in chronic thromboembolic pulmonary hypertension.

Circulation. 2007 Apr 24;115(16):2153-8.  

39. Krenn K, Klepetko W, Taghavi S, Paulus P, Aharinejad S.

Vascular endothelial growth factor increases pulmonary vascular permeability in cystic fibrosis patients undergoing lung transplantation.

Eur J Cardiothorac Surg. 2007 Jul;32(1):35-41.

40. Aigner C, Lang G, Taghavi S, Reza-Hoda MA, Marta G, Baumgartner H, Klepetko W.

Haemodynamic complications after pneumonectomy: atrial inflow obstruction and reopening of the foramen ovale. Eur J Cardiothorac Surg. 2007 Nov 29.

41. Aigner C, Jaksch P, Taghavi S, Lang G, Reza-Hoda MA, Wisser W, Klepetko W.

Pulmonary retransplantation: is it worth the effort? A long-term analysis of 46 cases.

J Heart Lung Transplant. 2008 Jan;27(1):60-5.

42. Aigner C, Lang G, Taghavi S, Reza-Hoda MA, Marta G, Baumgartner H, Klepetko W.

Haemodynamic complications after pneumonectomy: atrial inflow obstruction and reopening of the foramen ovale. Eur J Cardiothorac Surg. 2008 Feb;33(2):268-71.

43. Aigner C, Hoda MA, Lang G, Taghavi S, Marta G, Klepetko W.

Outcome after extrapleural pneumonectomy for malignant pleural mesothelioma.

Eur J Cardiothorac Surg. 2008 Jul;34(1):204-7.  2008 Apr 14.

44. Hacker S, Lambers C, Hoetzenecker K, Pollreisz A, Aigner C, Lichtenauer M, Mangold A, Niederpold T, Zimmermann M, Taghavi S, Klepetko W, Ankersmit HJ.

Elevated HSP27, HSP70 and HSP90 alpha in chronic obstructive pulmonary disease: markers for immune activation and tissue destruction.

Clin Lab. 2009;55(1-2):31-40.

45. Salama M, Andrukhova O, Hoda MA, Taghavi S, Jaksch P, Heinze G, Klepetko W, Aharinejad S.

Concomitant endothelin-1 overexpression in lung transplant donors and recipients predicts primary graft dysfunction.

Am J Transplant. 2010 Mar;10(3):628-36.

46. Salama M, Jaksch P, Andrukhova O, Taghavi S, Klepetko W, Aharinejad S.

Endothelin-1 is a useful biomarker for early detection of bronchiolitis obliterans in lung transplant recipients.

J Thorac Cardiovasc Surg. 2010 Dec;140(6):1422-7.

47. Lang G, Taghavi S, Aigner C, Charchian R, Matilla JR, Sano A, Klepetko W.

Extracorporeal membrane oxygenation support for resection of locally advanced thoracic tumors.

Ann Thorac Surg. 2011 Jul;92(1):264-70.

48.Salama M, Andrukhova O, Jaksch P, Taghavi S, Kelpetko W, Dekan G, Aharinejad S. Endothelin-1 governs proliferation and migration of bronchoalveolar lavage-derived lung mesenchymal stem cells in bronchiolitis obliterans syndrome.

Transplantation. 2011 Jul 27;92(2):155-62.

49. Kollmann D, Hoetzenecker K, Prosch H, Ankersmit, Aigner C, Taghavi S, Klepetko W.

Removal of a large cement embolus from the right pulmonary artery 4 years after kyphoplasty: consideration of thrombogenicity.

J Thorac Cardiovasc Surg. 2012 Apr;143(4).

50. Lang G, Taghavi S, Aigner C, Rényi-Vámos F, Jaksch P, Augustin V, Nagayama K, Ghanim B, Klepetko W.

Primary lung transplantation after bridge with extracorporeal membrane oxygenation: a plea for a shift in our paradigms for indications.

Transplantation. 2012 Apr 15;93(7):729-36.

51. Gruber S, Eiwegger T, Nachbaur E, Tiringer K, Aigner C, Jaksch P, Keplinger M, Klepetko W, Lang G, Taghavi S, Graf A, Eichler I, Frischer T, Szépfalusi Z.

Lung transplantation in children and young adults: a 20-year single-centre experience.

Eur Respir J. 2012 Aug;40(2):462-9.

52. Hoetzenecker K, Kollmann D, Schweiger T, Ankersmit , Aigner C, Lang G, Taghavi S, Klepetko W.

Unsuspected finding of a relapsing perichondritis during lung explantation.

Ann Thorac Surg. 2012 Oct;94(4):1353.

53. Moser B, Scharitzer M, Hacker S, Ankersmit J, Matilla JR, Lang G, Aigner C, Taghavi S, Klepetko W.

Thymomas and thymic carcinomas: prognostic factors and multimodal management.

Thorac Cardiovasc Surg. 2014 Mar;62(2):153-60.

54. Skoro-Sajer N, Marta G, Gerges C, Hlavin G, Nierlich P, Taghavi S, Sadushi-Kolici R, Klepetko W, Lang IM.

Surgical specimens, haemodynamics and long-term outcomes after pulmonary endarterectomy.

Thorax. 2014 Feb;69(2):116-22.

55. Jaksch P, Taghavi S, Klepetko W, Salama M.

Pretransplant serum human chitinase-like glycoprotein YKL-40 concentrations independently predict bronchiolitis obliterans development in lung transplant recipients.

J Thorac Cardiovasc Surg. 2014 Jul;148(1):273-81.

56. Mitterbauer A, Hoetzenecker K, Birner P, Mildner M, Prosch H, Streubel B, Taghavi S, Klepetko W, Ankersmit HJ.

Clinical-radiological, histological and genetic analyses in a lung transplant recipient with Mounier-Kuhn syndrome and end-stage chronic obstructive pulmonary disease.

Clin Respir J. 2015 Jul;9(3):375-9.

57. Lang G, Ghanim B, Hötzenecker K, Klikovits T, Matilla JR, Aigner C, Taghavi S, Klepetko W.

Extracorporeal membrane oxygenation support for complex tracheo-bronchial procedures†.

Eur J Cardiothorac Surg. 2015 Feb;47(2):250-5; discussion 256.

58. Schweiger T, Hoetzenecker K, Taghavi S, Klepetko W.

Extended cervico-thoracic metastasectomy for testicular non-seminomatous germ cell tumour masses through an inverse T and combined collar incision.

Eur J Cardiothorac Surg. 2015 May;47(5):931-3.

59. Lang G, Kim D, Aigner C, Matila J, Taghavi S, Jaksch P, Murakoezi G, Klepetko W.

Awake extracorporeal membrane oxygenation bridging for pulmonary retransplantation provides comparable results to elective retransplantation.

J Heart Lung Transplant. 2014 Dec;33(12):1264-72.

60. Moser B, Megerle A, Bekos C, Janik S, Szerafin T, Birner P, Schiefer AI, Mildner M, Lang I, Skoro-Sajer N, Sadushi-Kolici R, Taghavi S, Klepetko W, Ankersmit HJ.

Local and systemic RAGE axis changes in pulmonary hypertension: CTEPH and iPAH.

PLoS One. 2014 Sep

61. Schellongowski P, Riss K, Staudinger T, Ullrich R, Krenn CG, Sitzwohl C, Bojic A, Wohlfarth P, Sperr WR, Rabitsch W, Aigner C, Taghavi S, Jaksch P, Klepetko W, Lang G.

Extracorporeal CO2 removal as bridge to lung transplantation in life-threatening hypercapnia.

Transpl Int. 2015 Mar;28(3):297-304.

62. Klikovits T, Slama A, Hoetzenecker K, Waseda R, Lambers C, Murakoezy G, Jaksch P, Aigner C, Taghavi S, Klepetko W, Lang G, Hoda MA.

A rare indication for lung transplantation - pulmonary alveolar microlithiasis: institutional experience of five consecutive cases.

Clin Transplant. 2016 Apr;30(4):429-34.

63. Klikovits T, Lambers C, Ghanim B, Dome B, Murakoezy G, Zöchbauer-Müller S, Waseda R, Aigner C, Lang G, Taghavi S, Klepetko W, Jaksch P, Hoda MA.

Lung transplantation in patients with incidental early stage lung cancer-institutional experience of a high volume center.

Clin Transplant. 2016 Aug;30(8):912-7.

64. Kasiri MM, Beer L, Nemec L, Gruber F, Pietkiewicz S, Haider T, Simader EM, Traxler D, Schweiger T, Janik S, Taghavi S, Gabriel C, Mildner M, Ankersmit HJ.

Dying blood mononuclear cell secretome exerts antimicrobial activity.

Eur J Clin Invest. 2016 Oct;46(10):853-63.

65. Slama A, Schillab L, Barta M, Benedek A, Mitterbauer A, Hoetzenecker K, Taghavi S, Lang G, Matilla J, Ankersmit H, Hager H, Roth G, Klepetko W, Aigner C.

Standard donor lung procurement with normothermic ex vivo lung perfusion: A prospective randomized clinical trial.

J Heart Lung Transplant. 2017 Jul;36(7):744-753.

66. Moser B, Jaksch P, Taghavi S, Muraközy G, Lang G, Hager H, Krenn C, Roth G, Faybik P, Bacher A, Aigner C, Matilla JR, Hoetzenecker K, Hacker P, Lang I, Klepetko W.

Lung transplantation for idiopathic pulmonary arterial hypertension on intraoperative and postoperatively prolonged extracorporeal membrane oxygenation provides optimally controlled reperfusion and excellent outcome.

Eur J Cardiothorac Surg. 2018 Jan 1;53(1):178-185.

67. Aigner C, Slama A, Barta M, Mitterbauer A, Lang G, Taghavi S, Matilla J, Ullrich R, Krenn K, Jaksch P, Markstaller K, Klepetko W.

Treatment of primary graft dysfunction after lung transplantation with orally inhaled AP301: A prospective, randomized pilot study.

J Heart Lung Transplant. 2017 Sep.

68. Boehm PM, Ghanim BD, Matilla J, Klepetko W, Taghavi S.

Chylothorax in a 32-Year-Old Patient With Lymphangioleiomyomatosis After Bilateral Lung Transplant.

Ann Thorac Surg. 2018 Jun;105(6):e263-e264.

69. Hoetzenecker K, Schwarz S, Muckenhuber M, Benazzo A, Frommlet F, Schweiger T, Bata O, Jaksch P, Ahmadi N, Muraközy G, Prosch H, Hager H, Roth G, Lang G, Taghavi S, Klepetko W.

Intraoperative extracorporeal membrane oxygenation and the possibility of postoperative prolongation improve survival in bilateral lung transplantation.

J Thorac Cardiovasc Surg. 2018 May;155(5).

70. Skoro-Sajer N, Gerges C, Gerges M, Panzenböck A, Jakowitsch J, Kurz A, Taghavi S, Sadushi-Kolici R, Campean I, Klepetko W, Celermajer DS, Lang IM.

Usefulness of thrombosis and inflammation biomarkers in chronic thromboembolic pulmonary hypertension-sampling plasma and surgical specimens.

J Heart Lung Transplant. 2018 Sep;37(9):1067-1074.